Effect of Madhumehari Churna as an Adjuvant to Insulin Therapy in the management of Type 1 and Type 2 Diabetes Mellitus: Two Case Reports

Diabetes Mellitus is a syndrome characterized by chronic hyperglycemia due to insulin deficiency or insulin resistance. Type 1 Diabetes Mellitus (T1DM) is caused due to Insulin deficiency while type 2 Diabetes Mellitus (T2DM) is a consequence of insulin resistance. Though there is significant advancement in the treatment of this disease in terms of oral hypoglycemic drugs and Insulin therapy, still many patients face difficulty in achieving normal blood glucose levels and getting relief in their symptoms. The chronic hyperglycemia leads to a number of microvascular and macrovascular complications later on. The adoption of integrated treatment approach may pave a way to obtain the goal of treatment of this disease. This study reports the effect of Madhumehari Churna, a polyherbal formulation as an adjuvant in patients undergoing insulin therapy for Diabetes Mellitus. In this study, one patient was diagnosed with Type 1 Diabetes Mellitus and the other with type 2 Diabetes Mellitus. The patients were treated with Madhumehari Churna and relief in symptoms, improvement in blood sugar levels and glycosylated hemoglobin along with lowering of Insulin doses was observed in both cases.